Tower Research Capital LLC (Trc) Renovo Rx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,389 shares of RNXT stock, worth $8,349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,389
Previous 6,269
17.87%
Holding current value
$8,349
Previous $8,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RNXT
# of Institutions
19Shares Held
1.87MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1.1 Million0.27% of portfolio
-
Adar1 Capital Management, LLC Austin, TX355KShares$401,4210.08% of portfolio
-
Geode Capital Management, LLC Boston, MA144KShares$162,6280.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$109,7960.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny86.3KShares$97,5370.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $10.2M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...